for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

JP Business

European panel votes against Biogen’s Alzheimer’s drug

A European regulatory panel voted against approval of Biogen Alzheimer's disease drug, dealing a possible blow to the prospects of the drug already grappling with a slow rollout in the United States. Fred Katayama reports.

JP Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up